drugset / Trial / NCT05229913
Effects of Esketamine on Postpartum Depression
RandomizedSequentialDouble-blindTreatment
Summary
Different concentrations of Esketamine were used after cesarean section. Through the evaluation of postoperative psychological status and analgesic effect, the optimal dosage of Esketamine to exert the effects of depression and analgesia was analyzed.
Timeline
- Start
- 2022-02-20
- Primary completion
- 2022-09-30
- Completion
- 2023-06-30
Publications
- Background Suppa E, Valente A, Catarci S, Zanfini BA, Draisci G. A study of low-dose S-ketamine infusion as "preventive" pain treatment for cesarean section with spinal anesthesia: benefits and side effects. Minerva Anestesiol. 2012 Jul;78(7):774-81. Epub 2012 Feb 29.
- Background Krystal JH, Charney DS, Duman RS. A New Rapid-Acting Antidepressant. Cell. 2020 Apr 2;181(1):7. doi: 10.1016/j.cell.2020.02.033.
- Background Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, Tadic A, Sienaert P, Wiegand F, Manji H, Drevets WC, Van Nueten L. Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biol Psychiatry. 2016 Sep 15;80(6):424-431. doi: 10.1016/j.biopsych.2015.10.018. Epub 2015 Nov 3.
- Results O'Hara MW, McCabe JE. Postpartum depression: current status and future directions. Annu Rev Clin Psychol. 2013;9:379-407. doi: 10.1146/annurev-clinpsy-050212-185612. Epub 2013 Feb 1.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.2 mg/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 0.4 mg/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 0.6 mg/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 0.8 mg/kg | Intravenous |
| Background | Sufentanil | Other / unclassified | 1 ug/kg | Intravenous |
| Background | flurbiprofen axetil | Other / unclassified | 200 mg | Intravenous |
| Background | flurbiprofen axetil | Other / unclassified | 200 ml | Intravenous |